These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17516709)

  • 21. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New advances in antirejection therapy.
    Chan M; Pearson GJ
    Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
    J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients.
    Mehra MR; Uber PA; Park MH; Prasad AK; Scott RL
    Transplant Proc; 2001; 33(1-2):1606-7. PubMed ID: 11267438
    [No Abstract]   [Full Text] [Related]  

  • 29. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial.
    Grimm M; Rinaldi M; Yonan NA; Arpesella G; Arizón Del Prado JM; Pulpón LA; Villemot JP; Frigerio M; Rodriguez Lambert JL; Crespo-Leiro MG; Almenar L; Duveau D; Ordonez-Fernandez A; Gandjbakhch J; Maccherini M; Laufer G
    Am J Transplant; 2006 Jun; 6(6):1387-97. PubMed ID: 16686762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group.
    Mentzer RM; Jahania MS; Lasley RD
    Transplantation; 1998 Jan; 65(1):109-13. PubMed ID: 9448154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
    Li W; Lu L; Li Y; Fu F; Fung JJ; Thomson AW; Qian S
    Transplant Proc; 1997; 29(1-2):1081-2. PubMed ID: 9123209
    [No Abstract]   [Full Text] [Related]  

  • 32. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
    Starzl TE; Todo S; Demetris AJ; Fung JJ
    Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S7-14. PubMed ID: 9631858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter.
    Mehra MR; Uber PA; Kaplan B
    Am J Transplant; 2006 Jun; 6(6):1243-5. PubMed ID: 16686745
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppressive therapy in older cardiac transplant patients.
    Aliabadi AZ; Zuckermann AO; Grimm M
    Drugs Aging; 2007; 24(11):913-32. PubMed ID: 17953459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.
    Spencer CM; Goa KL; Gillis JC
    Drugs; 1997 Dec; 54(6):925-75. PubMed ID: 9421697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy.
    Crespo-Leiro MG; Paniagua MJ; Mosquera I; Tabuyo T; De la Fuente L; Bouzas B; Rodriguez JA; Hermida LF; Juffé A; Castro-Beiras A
    Transplant Proc; 2002 Feb; 34(1):113-4. PubMed ID: 11959213
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
    Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH
    Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation.
    Testa G; Klintmalm GB
    Clin Liver Dis; 1997 Aug; 1(2):417-37, x. PubMed ID: 15562576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection.
    Chan MC; Kwok BW; Shiba N; Cantin B; Valantine HA; Hunt SA
    Transplant Proc; 2002 Aug; 34(5):1850-2. PubMed ID: 12176601
    [No Abstract]   [Full Text] [Related]  

  • 40. Tacrolimus: a new immunosuppressive agent.
    Kelly PA; Burckart GJ; Venkataramanan R
    Am J Health Syst Pharm; 1995 Jul; 52(14):1521-35. PubMed ID: 7552894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.